Oxytocin intranasal administration as a new hope for hypogonadotropic hypogonadism patients.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Medical Hypotheses

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mehy.2017.09.020PMID 29150303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxytocin Intranasal Administration Affects Neural Networks Upstream of GNRH Neurons

  2017cited by this paper
• Physiology of the Adult Gonadotropin-Releasing Hormone Neuronal Network

  2015cited by this paper
• An update on male hypogonadism therapy

  2014cited by this paper
• Intranasal administration of oxytocin: Behavioral and clinical effects, a review

  2013cited by this paper
• Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice.

  2013cited by this paper
• Hypogonadotropic Hypogonadism Revisited

  2013cited by this paper
• TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction

  2009cited by this paper
• What is the optimal therapy for young males with hypogonadotropic hypogonadism?

  2009cited by this paper
• Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene

  2007cited by this paper
• Presence of Oxytocin Receptors in the Gonadotrophin‐Releasing Hormone (GnRH) Neurones in Female Rats: A Possible Direct Action of Oxytocin on GnRH Neurones

  2007cited by this paper
• Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene.

  2007cited by this paper
• Hypogonadotropic hypogonadism.

  2007cited by this paper
• Interaction Between Norepinephrine, Oxytocin, and Nitric Oxide in the Stimulation of Gonadotropin‐Releasing Hormone Release From Proestrous Rat Basal Hypothalamus Explants

  2004cited by this paper
• Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.

  2004cited by this paper
• Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.

  2004cited by this paper
• Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54

  2003cited by this paper
• Gene regulation in the magnocellular hypothalamo-neurohypophysial system.

  2001cited by this paper
• Central Stimulatory Influence of Oxytocin on Preovulatory Gonadotropin-Releasing Hormone Requires More than the Median Eminence

  2001cited by this paper
• Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamic explants by releasing nitric oxide.

  1997cited by this paper
• Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate.

  1995cited by this paper
• Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males.

  1993cited by this paper
• Male hypogonadotropic hypogonadism.

  1993cited by this paper
• Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism.

  1991cited by this paper
• Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism.

  1991cited by this paper
• Physiologically important role for central oxytocin in the preovulatory release of luteinizing hormone.

  1990cited by this paper

• Testosterone in long-term sedentary aging males: Effect of antiaging strategies.

  2025cites this paper
• The role of anti-aging approaches in managing hypogonadism in sedentary older males

  2024cites this paper
• Co-Stimulation of Oxytocin and Arginine-Vasopressin Receptors Affect Hypothalamic Neurospheroid Size

  2021cites this paper
• Neuropeptides as regulators of the hypothalamus-pituitary-gonadal (HPG) axis activity and their putative roles in stress-induced fertility disorders.

  2021cites this paper
• Non-testosterone management of male hypogonadism: an examination of the existing literature

  2020cites this paper